BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2019
View Archived Issues
Brain kinase induces spinal cord regeneration
Read More
Microfluidics method broadens human iPSC potential
Read More
Brain regulatory T cells potentiate neurological recovery
Read More
Oppilan Pharma initiates phase I study of OPL-002
Read More
Regulus announces clinical candidate nomination for RGLS-5579 for GBM
Read More
Oncolys BioPharma initiates phase II study of Telomelysin in combination with pembrolizumab
Read More
Patient enrollment begins in phase II study of CPI-613 in Burkitt lymphoma/leukemia
Read More
Kymab initiates phase II study of KY-1005 in atopic dermatitis
Read More
Patient recruitment ongoing in first-in-human study of IBI-101
Read More
Georgia State University describes new carbon monoxide-releasing molecules
Read More
Tarlige tablets receive approval in Japan for the treatment of peripheral neuropathic pain
Read More
Inovio initiates first-in-human study of DNA-encoded monoclonal antibody for Zika
Read More
The General Hospital Corp. patents new CYP1 inhibitors
Read More
Combining novel MCL-1 inhibitor with MEK inhibitors as promising new strategy in KRAS-mutant NSCLC
Read More
Genentech and Roche disclose IRAK-4 inhibitors
Read More
Medshine Discovery presents TLR8 agonists
Read More
CX-23, an NQO1-selective activated prodrug of triptolide, shows promise in preclinical models of HCC
Read More
Chinese researchers identify compounds for estrogen receptor-mediated diseases
Read More
Spero and Everest Medicines sign license and option agreements for SPR-206 and SPR-741 in Asia
Read More
Japan first to approve Evenity for osteoporosis
Read More
MediciNova opens enrollment in phase I/II study of MN-166 with temozolomide in GBM
Read More
Demser approved in Japan to improve catecholamine excess secretion in patients with pheochromocytoma
Read More
Japanese approval for Braftovi and Mektovi for unresectable melanoma with BRAF mutation
Read More
Wockhardt presents first clinical data for WCK-5222 in patients with renal impairment
Read More
IAVI initiates phase I trial of BG505 SOSIP.664 gp140 in HIV-uninfected subjects
Read More